Cargando…
SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the 5-year relative overall survival (OS) rate is less than 20%. Since there are no specific symptoms, most patients with HCC are diagnosed in an advanced stage with poor prognosis. Therefore, identifying novel prognostic bio...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648382/ https://www.ncbi.nlm.nih.gov/pubmed/37968735 http://dx.doi.org/10.1186/s40001-023-01347-5 |